Chemed (CHE)
(Delayed Data from NYSE)
$604.42 USD
+4.01 (0.67%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $604.37 -0.05 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
CHE 604.42 +4.01(0.67%)
Will CHE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CHE
Here's Why You Should Retain Chemed (CHE) Stock for Now
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
Other News for CHE
Additions and deletions of Oppenheimer’s OPCO Trifecta
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS completes purchase of assets in Florida, Alabama
Analysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25